نتائج البحث

Immunotherapy Study for Patients With Stage IV Melanoma

• Source: A Phase 2b Study of Immune Checkpoint Inhibition With or Without Dorgenmeltucel-L (HyperAcute Melanoma) Immunotherapy for Stage IV Melanoma Patients

تفاصيل العنوان

CD133 Expression in Mammary Invasive Ductal Carcinoma

• Authors : Nagwa Abd El-Sadek Ahmed, Lecturer at Pathology Department, Faculty of Medicine, Sohag University

• Source: Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast

تفاصيل العنوان

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

• Authors : Seventh Framework Programme; University of Groningen; University Medical Center Groningen

• Source: A Randomised, Double-blind, Placebo-controlled, Single-centre Phase IIb Trial as Part of the EU-funded UNISEC Project to Assess the Immunogenicity and Safety of Different Formulations and Dosing

تفاصيل العنوان

Vaccine Treatment for Hormone Refractory Prostate Cancer

• Authors : Nicholas N. Vahanian, M.D., Chief Medical and Operations Officer

• Source: A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Hormone Refractory Prostate Cancer

تفاصيل العنوان

Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer

• Source: An Exploratory Phase 2 Study of Neoadjuvant Chemotherapy Followed by Stereotactic Body Radiation Therapy (SBRT) With Algenpantucel-L (HyperAcute®-Pancreas) Immunotherapy in Subjects With Borderline

تفاصيل العنوان

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (PILLAR)

• Source: A Phase III Study of Chemotherapy With or Without Algenpantucel-L (HyperAcute®-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

تفاصيل العنوان

Vaccine Treatment for Advanced Breast Cancer

• Authors : Nicholas N. Vahanian, M.D., Chief Medical and Operations Officer

• Source: A Phase I/II Study of an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Relapsed or Refractory Breast Cancer

تفاصيل العنوان

Vaccine Treatment for Surgically Resected Pancreatic Cancer

• Authors : Nicholas N. Vahanian, M.D., Chief Medical and Operations Officer

• Source: A Phase I/II Study of Algenpantucel-L (HyperAcute Pancreas) an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Pancreatic Cancer

تفاصيل العنوان

Vaccine Treatment for Advanced Malignant Melanoma

• Authors : Nicholas N. Vahanian, M.D., Chief Medical and Operations Officer

• Source: A Phase I/II Study of Dorgenmeltucel-L (HyperAcute Melanoma) an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Refractory or Recurrent

تفاصيل العنوان

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) (PReSuTINeB)

• Authors : National Institute for Health Research, United Kingdom; Oxford Clinical Trials Research Unit

• Source: Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method StudyEsclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera

تفاصيل العنوان